Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

Launched by UNIVERSITY HOSPITAL, LIMOGES · Jun 24, 2019

Keywords

ClinConnect Summary

This clinical trial, titled "Optimizing Long-term Survival in Organ Transplantation," is focused on improving the success of organ transplants and enhancing the quality of life for transplant recipients. The study aims to understand how to better manage the care of patients who have received organs, such as kidneys, livers, or hearts, to reduce the risks of chronic rejection and long-term complications. Researchers will evaluate factors related to the donor, the organ, and the recipient, and will also provide personalized follow-up care to help predict and prevent transplant rejection.

To participate in this trial, individuals must be at least 18 years old and have received a kidney, liver, or heart transplant. They should be under the care of one of the designated medical centers associated with the study and must agree to take part by providing informed consent. Participants can expect to be involved in a program that monitors their health closely and may help improve their long-term outcomes after transplantation. This trial is currently recruiting and aims to gather valuable information that could lead to better management practices for future transplant patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female over 18 (no age limit)
• • affiliated to a social security organization
• • Recipient (s) of a kidney, liver or heart transplant
• • followed by at least one of the FHU SUPORT centers (Tours, Poitiers, Limoges, Rennes)
• • having given informed consent to participate in the cohort.
• Exclusion Criteria:
• • Patient unable to understand the information given by the investigator
• • People under the protection of justice